Hearts hope to complete the signing of 28-year-old Falkirk winger Calvin Miller this week. (Scottish Sun), external
Celtic, Feyenoord, Bodo-Glimt and Jens Berthel Askou’s Toulouse are showing an interest in Sandefjord centre-back Zinedin Smajlovic, for whom the Norwegian club would want a record fee of at least £2.6m. (TV2 – in Norwegian), external
Celtic and Wolverhampton Wanderers are showing interest in Alfie Devine despite Preston North End triggering an option to enter signing talks with the Tottenham Hotspur 21-year-old pending a £6m transfer following the midfielder’s loan spell. (Football London), external
Aberdeen are closing in on a summer transfer window deal to sign 28-year-old former St Mirren midfielder Connor Ronan, whose contract with Major League Soccer club Colorado Rapids runs out at the end of the calendar year. (Press & Journal), external
Western Sydney Wanderers are keen on re-signing out-of-favour Nicolas Milanovic from Aberdeen, to whom they sold the 24-year-old winger for £400,000 last summer. (Daily Record), external
Scottish Gossip: Miller, Devine, Smajlovic, Ronan, Milanovic, Adamson, Dewar Top World News Today.
Hence then, the article about scottish gossip miller devine smajlovic ronan milanovic adamson dewar was published today ( ) and is available on TOP world News today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scottish Gossip: Miller, Devine, Smajlovic, Ronan, Milanovic, Adamson, Dewar )
Also on site :
- Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion
- 2026 ASCO .. Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC
- D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC